BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22495812)

  • 1. Proton pump inhibitor use and Clostridium difficile colitis: cause or coincidence?
    McCarthy DM
    J Clin Gastroenterol; 2012; 46(5):350-3. PubMed ID: 22495812
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of proton pump inhibitor types for Clostridium difficile infection.
    Kim YG; Jang BI
    J Clin Gastroenterol; 2013 Mar; 47(3):292. PubMed ID: 23391870
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of proton pump inhibitor types for Clostridium difficile infection.
    Alagozlu H; Karakan T
    J Clin Gastroenterol; 2013 Mar; 47(3):290. PubMed ID: 23164689
    [No Abstract]   [Full Text] [Related]  

  • 4. Proton pump inhibitor use may be associated with an increased risk of Clostridium difficile infection.
    Stevens V; van Wijngaarden E
    Evid Based Med; 2013 Oct; 18(5):193-4. PubMed ID: 23220471
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea?
    Freedberg DE; Abrams JA
    Am J Gastroenterol; 2013 Feb; 108(2):278-9. PubMed ID: 23381076
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Freedberg and Abrams.
    Adler DG
    Am J Gastroenterol; 2013 Feb; 108(2):279. PubMed ID: 23381078
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.
    Chandra S; Agarwal D; Surana A
    Am J Gastroenterol; 2013 Feb; 108(2):277-8. PubMed ID: 23381074
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Chandra et al., and Freedberg and Abrams.
    Loke YK; Kwok CS
    Am J Gastroenterol; 2013 Feb; 108(2):279-80. PubMed ID: 23381077
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium difficile colitis: wash your hands before stopping the proton pump inhibitor.
    Metz DC
    Am J Gastroenterol; 2008 Sep; 103(9):2314-6. PubMed ID: 18924259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
    Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
    J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors: Clostridium difficile infections.
    Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and the risk for Clostridium difficile infection.
    Famularo G; Gasbarrone L; De Simone C
    JAMA; 2009 Jul; 302(1):31-2; author reply 32. PubMed ID: 19567433
    [No Abstract]   [Full Text] [Related]  

  • 14. Reflux drugs linked to C. difficile-related diarrhea.
    Kuehn BM
    JAMA; 2012 Mar; 307(10):1014. PubMed ID: 22416090
    [No Abstract]   [Full Text] [Related]  

  • 15. How much do PPIs contribute to C. difficile infections?
    Leontiadis GI; Miller MA; Howden CW
    Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools.
    Hauben M; Horn S; Reich L; Younus M
    Int J Infect Dis; 2007 Sep; 11(5):417-22. PubMed ID: 17336566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
    Aseeri M; Schroeder T; Kramer J; Zackula R
    Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.
    Ziolkowski SL; Malabanan MH; Liebman SE
    Perit Dial Int; 2015; 35(5):586-7. PubMed ID: 26450478
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
    Villafuerte-Gálvez JA; Kelly CP
    Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.